{"id":"W2922526627","doi":"10.1016/j.bpg.2019.03.002","title":"Pharmacology, efficacy and safety of JAK inhibitors in Crohn’s disease","year":2019,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology; American Gastroenterological Association","keywords":"Medicine; Tofacitinib; Clinical endpoint; Clinical trial; Internal medicine; Placebo; Phases of clinical research; Crohn's disease; Janus kinase; Pharmacology; Oncology; Disease; Cytokine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001033817,0.000707814,0.002159595,0.001175967,0.0001801939,0.001163113,0.0008783403,0.0009840722,0.002774293],"category_scores_gemma":[0.001254253,0.0002619924,0.0006650672,0.0012348,0.0004509916,0.000847284,0.0004650321,0.002607913,0.001379181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000582011,"about_ca_system_score_gemma":0.0008213706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009355988,"about_ca_topic_score_gemma":0.002500303,"domain_scores_codex":[0.9997473,0.00005071035,0.00004387318,0.00003785366,0.00009458558,0.00002564005],"domain_scores_gemma":[0.9994738,0.000299619,0.00008994743,0.00001139022,0.00009054023,0.00003473816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003827413,0.00009690728,0.0001566251,0.01474892,0.0001782797,0.0001095931,0.00002314616,0.0004122345,0.001121216,0.001681246,0.02062807,0.9604611],"study_design_scores_gemma":[0.0003330731,0.000480326,0.002117239,0.007843721,0.0006720583,0.001291524,0.00005189654,0.0002639581,0.0007619162,0.002819573,0.9833201,0.00004454824],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009151389,0.9992537,0.00004761249,0.0001874004,0.00009290257,0.000002152882,0.00001427552,0.000003198081,0.0003072029],"genre_scores_gemma":[0.0007562012,0.9983581,0.0001137603,0.0002616228,0.0001847588,0.000004476202,0.00002351033,9.716623e-7,0.0002966424],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002774293,"threshold_uncertainty_score":0.00928098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1082905367393629,"score_gpt":0.4957671911948989,"score_spread":0.387476654455536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}